As of 2024, Veeva Systems net worth is reflective of its growing client base and innovative cloud solutions. Major partnerships, especially in life sciences, have fueled its substantial revenue growth.
At Ando Money, we’ll take you through an in-depth look at how Veeva’s financials stack up in today’s competitive landscape.
Quick Facts
| FACT | DETAIL |
|---|---|
| Name | Veeva Systems |
| Full Name | Veeva Systems Inc. |
| Website | veeva.com |
| Industry | Cloud Software, Life Sciences |
| Traded as | NYSE: VEEV |
| ISIN | US9224751084 |
| Founded | 2007 |
| Founders | Peter Gassner |
| Country/Territory | United States |
| Headquarters | Pleasanton, California, USA |
| Chief Executive Officer | Peter Gassner |
| Number of Employees | Over 6,000 (2024) |
| Market Cap | $35.19 billion |
| Total Assets | $6.33 billion (2024) |
| Total Equity | $5.18 billion (2024) |
| Revenue | $676.2 million (Q2 2025) |
| Net Income | $171 million (Q2 2025) |
What is the Net Worth/Market Cap Of Veeva Systems in 2024?
As of October 2024, Veeva Systems’ net worth is primarily represented by its market capitalization, standing at $35.19 billion. This positions Veeva among the top 600 most valuable companies worldwide.
Compared to other players in the life sciences and cloud software industries, Veeva’s steady financial growth reflects the company’s strategic focus on client success and innovation.
If you’re curious about how Veeva compares to others in the industry, here’s a list of related companies:
Explore more about the top earning companies in the industry by checking our full analysis.
Veeva Systems Financial Performance Overview
Key Revenue Streams Driving Financial Growth
Veeva’s revenue comes from two primary streams: subscription services and professional services.
In Q2 of fiscal 2025, subscription services revenue amounted to $561.3 million, making up the majority of the total revenue, which grew by 19% year-over-year.
Veeva’s R&D Solutions and Commercial Solutions play a key role, contributing significantly to this growth by attracting new clients from biopharma and life sciences sectors.
As these industries continue to evolve, Veeva remains a trusted partner, innovating and expanding its product suite.
Impact of Major Client Contracts on Revenue
The financial success of Veeva is closely tied to its partnerships with top biopharma companies.
Over the past year, Veeva has secured contracts with emerging biotech companies and expanded existing relationships with leading pharmaceutical firms.
These contracts contribute to a steady and reliable revenue stream, which is expected to grow as clinical data solutions like Veeva Vault gain momentum.
Subscription Services Contribution to Revenue
Veeva’s subscription services, which contribute $561.3 million in Q2 2025, are critical to the company’s sustained growth.
With a high-margin model, subscription services continue to dominate Veeva’s revenue structure.
Looking ahead, subscription-based models are expected to drive long-term profitability, particularly as Veeva expands into new cloud-based software offerings.
Innovations in Cloud Solutions
Veeva’s commitment to innovation has a direct financial impact, with recent developments in Vault CRM and clinical data platforms helping to streamline operations for biopharma companies.
The introduction of Site Connect for clinical trials has also added efficiency, reducing costs for clients and solidifying Veeva’s role as a leader in cloud-based solutions.
These innovations not only enhance Veeva’s product suite but also contribute to substantial year-over-year revenue growth.
Geographic Expansion and Its Effect on Revenue
Veeva’s expansion into international markets, including Europe and Asia, has significantly boosted its revenue.
By entering these markets, Veeva is able to tap into a larger client base and offer its cloud solutions to new biopharma players in emerging markets.
his geographic diversification allows the company to mitigate risks tied to any single market, ensuring steady revenue streams globally.
Research and Development Investments and ROI
Veeva consistently invests in research and development, a strategy that has paid off through its innovative solutions.
With over $176.4 million spent on R&D in Q2 2025, these investments have led to the launch of several key products that not only improve client efficiency but also drive significant financial returns.
By focusing on long-term innovation, Veeva is setting the stage for sustained growth in the coming years.
Operating Income and Efficiency Improvements
Veeva’s operating income for Q2 2025 was $166.5 million, a 60% increase from the previous year.
This jump is the result of cost-efficiency measures that the company has implemented, improving its operating margins and ensuring continued profitability.
As the company continues to streamline its operations, we expect to see more improvements in overall income.
Strategic Focus on Long-Term Profitability
Looking toward the future, Veeva aims to maintain its strong financial performance by focusing on its life sciences clients and continually innovating its product offerings.
With revenue projections between $2.704 billion and $2.710 billion for fiscal 2025, the company is well-positioned for long-term growth.
By emphasizing client success and operational efficiency, Veeva is set to remain a major player in the life sciences cloud software sector through 2030 and beyond.
FAQs about Veeva Systems
How does Veeva generate most of its revenue?
It generates the majority of its revenue through subscription services for its cloud-based software products. These include both Commercial Solutions and R&D Solutions, which cater to the life sciences industry.
What are Veeva’s key products?
Its key products include Vault CRM, Site Connect, and its Clinical Database (CDB). These solutions streamline processes for clients, particularly in the biopharma and clinical trial sectors.
Where is Veeva headquartered?
Its headquarters is located in Pleasanton, California, USA.
How many employees does Veeva have?
As of 2024, the company employs over 6,000 people globally.
What was Veeva’s revenue in 2024?
For Q2 2025, the company reported total revenues of $676.2 million, reflecting a 15% year-over-year growth.
Conclusion
At Ando Money, we hope this in-depth look at Veeva Systems’ financial performance has provided valuable insights.
Feel free to explore more content, leave comments, or share your thoughts with us. For more analysis, visit https://www.andomoney.com/.
